PCN532 WOMEN'S PREFERENCES ON BENEFITS, RISKS, AND SIDE EFFECTS OF MAINTENANCE PARP INHIBITOR THERAPY IN OVARIAN CANCERL. J. Havrilesky, S. L. Lim,J. A. Ehrisman,A. Lorenzo,Alvarez A. Secord,J. C. Yang,F. R. Johnson,S. D. ReedValue in health（2019）引用 0|浏览53暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
